Developments in healthcare policy often mirror the gravest issues faced by patients and their care units on the ground. Effective from July 1, 2024, the Center for Medicare and Medicaid Innovation (“CMMI”) is set to introduce a value-based payment model formulated specifically to tackle the severe effects of dementia or Alzheimer’s Disease diagnoses on patients and their supportive networks consisting of family, friends, and ancillary caregivers.
Called the Guiding an Improved Dementia Experience (“GUIDE”) model, the initiative has been crafted by the Centers for Medicare and Medicaid Services (“CMS”) with particular emphasis on healthcare provision for patients living with these debilitating cognitive conditions. Epstein Becker & Green reports more on this forthcoming care model and its implications.
The GUIDE model differs from traditional care paradigms by its comprehensive addressal of the arduous journey that dementia and Alzheimer’s Disease patients and their caregivers step on post-diagnosis. This is projected to dramatically better the quality of life for these individuals in a tangible manner. Additionally, as a ground-breaking development in the healthcare payment modality, GUIDE brings the focus to value-based payment, upturning the conventional norm of rewarding volume of care provision.
As attorneys and legal advisors working in the healthcare sector, it is essential to keep abreast with these sweeping transformations in healthcare management and payment systems. Such insight is crucial to the provision of sound, timely counsel to clients who might be affected by the implementation of such models.
Keep an eye on how CMS implements the GUIDE model and make note of the resultant shifts in the healthcare landscape. These observations will be invaluable in navigating the future of healthcare law and policy.
Visit this page for more information on the GUIDE model and what it means for the realm of healthcare and its interconnected policy elements.